• F. Hoffmann-La Roche Ltd.
• Bristol Myers Squibb Company
• Merck & Co. Inc.
• Novartis AG
• Eli Lilly And Company
• Pfizer Inc.
• Johnson & Johnson
• Otsuka Pharmaceutical Co. Ltd.
• Yamo Pharmaceuticals
• Curemark LLC
Published | Pages | Publisher | Report code |
---|---|---|---|
Sep 2023 | 135 | KBV Research | ASDR-659602 |
• F. Hoffmann-La Roche Ltd.
• Bristol Myers Squibb Company
• Merck & Co. Inc.
• Novartis AG
• Eli Lilly And Company
• Pfizer Inc.
• Johnson & Johnson
• Otsuka Pharmaceutical Co. Ltd.
• Yamo Pharmaceuticals
• Curemark LLC